Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundAbnormalities in resting-state electroencephalogram (rsEEG) posterior alpha rhythm are promising biomarkers of neurodegenerative diseases (NDDs), often assessed via spectral analysis, ignoring the signal's non-rhythmic (aperiodic) component. Evidence assessing aperiodic and oscillatory rsEEG abnormalities across NDDs is scarce and often underpowered. Multicenter studies could tackle these limitations, but data pooling might introduce site-related rsEEG differences (batch effects). This study aims to characterize rsEEG oscillatory and aperiodic patterns across NDDs, minimizing potential batch effects.MethodsRsEEGs (n = 639; 11 sites) were automatically preprocessed. Signals comprised healthy controls (HC = 153), Lewy Body Dementias (LBD = 95), Parkinson's Disease (PD = 71), Alzheimer's Disease (AD = 186), Frontotemporal Dementia (FTD = 23), Mild Cognitive Impairment (MCI) in positive Lewy Bodies pathology or PD (MCI-LBD = 34), and MCI in positive AD pathology (MCI-AD = 77). Power spectrum batch effects were harmonized using reComBat (age, sex, and diagnosis-adjusted). Harmonization was evaluated with functional and mass-univariate ANOVAs. Oscillatory and aperiodic parameters were extracted from the batch-harmonized power spectrum. NDDs-related differences were estimated with functional and mass-univariate tests, bootstrapped pairwise comparisons, and logistic regressions.ResultsStatistical testing showed reduced batch effects after harmonization. Significantly steeper aperiodic parameters and lower oscillatory center frequency were observed in LBD compared to other NDDs. The oscillatory extended alpha power was lower in AD comparisons (except AD vs. LBD).ConclusionsBatch effects in the rsEEG power spectrum can be mitigated with harmonization. Oscillatory alpha power reduction may better reflect AD abnormalities, whereas pronounced oscillatory frequency slowing and greater aperiodic activity characterize LBD.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.